How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

335 results for

aspirin and Reye syndrome

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 This site uses (...) cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association , MD, FAHA, Chair , MD, PhD, FAHA, Vice Chair , MD, PhD , PhD, FAHA , MD, MSPH, FAHA , MD, MPH, FAHA , MD , MD , MD, MSCE , DO , and MD, MPH, FAHA MD, FAHAOn behalf of the American Heart Association Cardiovascular Disease in Women

2018 American Heart Association

22. Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease Full Text available with Trip Pro

on the systemic ventricle prior to future staged procedures. For patients with hypoplastic left heart syndrome (HLHS), the stage 1 Norwood palliation typically involves 3 key steps: (1) reconstruction of the aorta and systemic outflow; (2) Downloaded from http://ahajournals.org by on March 27, 2019Marino et al CPR in Infants and Children With Cardiac Disease May 29, 2018 Circulation. 2018;137:e691–e782. DOI: 10.1161/CIR.0000000000000524 e694 CLINICAL STATEMENTS AND GUIDELINES atrial septectomy to ensure (...) aspirin use. †For comparative effectiveness recommendations (Class I and IIa; Level of Evidence A and B only), studies that support the use of comparator verbs should involve direct comparisons of the treatments or strategies being evaluated. Downloaded from http://ahajournals.org by on March 27, 2019Marino et al CPR in Infants and Children With Cardiac Disease Circulation. 2018;137:e691–e782. DOI: 10.1161/CIR.0000000000000524 May 29, 2018 e695 CLINICAL STATEMENTS AND GUIDELINES the pulmonary vascular

2018 American Heart Association

23. Pharmacotherapy in Chronic Kidney Disease Patients Presenting With Acute Coronary Syndrome Full Text available with Trip Pro

Pharmacotherapy in Chronic Kidney Disease Patients Presenting With Acute Coronary Syndrome AHA Scientific Statement 1123 C hronic kidney disease (CKD) is frequently encoun- tered among patients presenting with acute coro- nary syndrome (ACS). Recent data from the National Cardiovascular Data Registry–Acute Coronary Treatment and Intervention Outcomes Network (NCDR-ACTION) reported CKD (defined as estimated creatinine clearance [CrCl] 2.5 mg/dL), and 274 777 non-CKD patients. 14 Those (...) not reported in this analysis ACS indicates acute coronary syndrome; ACSIS, Acute Coronary Syndromes Israeli Survey; CI, confidence interval; CKD, chronic kidney disease; CrCl, creatinine clearance; CRI, chronic renal insufficiency; ESRD, end-stage renal disease; GFR, glomerular filtration rate; GRACE, Global Registry of Acute Coronary Events; HR, hazard ratio; ICH, intracranial hemorrhage; ICONS, Improved Cardiac Outcomes in Nova Scotia; LBBB, left bundle branch block; OR, odds ratio; PCI, percutaneous

2015 American Heart Association

24. Diagnosis and treatment of respiratory illness in children and adults.

should not be used for longer than 72 hours, owing to the potential for rebound congestion. Aspirin is not recommended for children because of the risk of Reye's syndrome. Aspirin, ibuprofen and naproxen should be avoided by persons who are not eating well (risk of gastrointestinal upset), have a history of peptic ulcer or related disorder, or have aspirin-sensitive asthma, coronary artery disease or have renal dysfunction. Avoid using honey preparations for children under one year because (...) guideline document (see the "Guideline Availability" field): Main Algorithm Acute Pharyngitis Algorithm Non-Infectious Rhinitis Algorithm Acute Sinusitis Algorithm Respiratory illnesses: Viral upper-respiratory infection Acute pharyngitis Non-infectious rhinitis (allergic and nonallergic) Acute sinusitis Diagnosis Evaluation Management Treatment Allergy and Immunology Family Practice Infectious Diseases Internal Medicine Otolaryngology Pediatrics Advanced Practice Nurses Allied Health Personnel Health

2017 National Guideline Clearinghouse (partial archive)

25. Interventions Targeting Sensory Challenges in Children with Autism Spectrum Disorder - An Update

and cerebellum of three older men with fragile X syndrome. Mol Autism. 2011;2(1):2. doi: 10.1186/2040-2392-2-2. PMID: 21303513.X-1 653. Greer RD, Pistoljevic N, Cahill C, et al. Effects of conditioning voices as reinforcers for listener responses on rate of learning, awareness, and preferences for listening to stories in preschoolers with autism. Anal Verbal Behav. 2011;27(1):103- 24. PMID: 22532758.X-1, X-3, X-4 D-56 654. Griffith GM, Hastings RP, Oliver C, et al. Psychological well-being in parents (...) of children with Angelman, Cornelia de Lange and Cri du Chat syndromes. J Intellect Disabil Res. 2011 Apr;55(4):397-410. doi: 10.1111/j.1365-2788.2011.01386.x. PMID: 21323782.X-1 655. Grow LL, Carr JE, Kodak TM, et al. A comparison of methods for teaching receptive labeling to children with autism spectrum disorders. J Appl Behav Anal. 2011 Fall;44(3):475-98. doi: 10.1901/jaba.2011.44-475. PMID: 21941380.X-3, X-4 656. Guénolé F, Baleyte J-M. Melatonin for sleep-disturbed children with autism spectrum

2017 Effective Health Care Program (AHRQ)

26. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association Full Text available with Trip Pro

of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acquired heart disease in children in developed countries. Methods and Results: To revise the previous American Heart Association guidelines, a multidisciplinary writing group of experts was convened to review and appraise available evidence and practice-based opinion, as well as to provide updated recommendations for diagnosis, treatment of the acute illness, and long (...) and current involvement. Patients with aneurysms require life-long and uninterrupted cardiology follow-up. Conclusions: These recommendations provide updated and best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but clinical decision making should be individualized to specific patient circumstances. Kawasaki disease (KD) is an acute, self-limited febrile illness of unknown cause that predominantly affects children <5 years of age. When initially described

2017 American Heart Association

27. Aspirin Increases Mitochondrial Fatty Acid Oxidation Full Text available with Trip Pro

into mitochondria. The drive on mitochondrial fatty acid oxidation may be a compensatory response to altered mitochondrial morphology and inhibited electron transport chain function, both of which were observed after 24 h incubation of cells with aspirin. These studies provide insight into the pathophysiology of Reye Syndrome, which is known to be triggered by aspirin ingestion in patients with fatty acid oxidation disorders.Copyright © 2016 Elsevier Inc. All rights reserved. (...) Aspirin Increases Mitochondrial Fatty Acid Oxidation The metabolic effects of salicylates are poorly understood. This study investigated the effects of aspirin on fatty acid oxidation. Aspirin increased mitochondrial long-chain fatty acid oxidation, but inhibited peroxisomal fatty acid oxidation, in two different cell lines. Aspirin increased mitochondrial protein acetylation and was found to be a stronger acetylating agent in vitro than acetyl-CoA. However, aspirin-induced acetylation did

2016 Biochemical and biophysical research communications

28. Toxicity, Salicylate (Diagnosis)

to moderate pain. Aspirin is used as an antipyretic and as an anti-inflammatory agent for the treatment of soft tissue and joint inflammation and vasculitides such as acute rheumatic fever and Kawasaki disease. Aspirin is also used to treat acute coronary syndrome. Low-dose aspirin helps to prevent thrombosis. Acetylsalicylic acid is colorless or white in crystalline, powder, or granular form. The chemical is odorless and is soluble in water. Salicylate is available for ingestion as tablets, capsules (...) . Repackaging has decreased children's accessibility to lethal amounts, and salicylate's association with Reye syndrome has significantly decreased its use. Still, more than 10,000 tons of aspirin are consumed in the United States each year. Aspirin or aspirin-equivalent preparations (in milligrams) include children's aspirin (80-mg tablets with 36 tablets per bottle), adult aspirin (325-mg tablets), methyl salicylate (eg, oil of wintergreen; 98% salicylate), and Pepto-Bismol (236 mg of non-aspirin

2014 eMedicine.com

29. Toxicity, Salicylate (Overview)

to moderate pain. Aspirin is used as an antipyretic and as an anti-inflammatory agent for the treatment of soft tissue and joint inflammation and vasculitides such as acute rheumatic fever and Kawasaki disease. Aspirin is also used to treat acute coronary syndrome. Low-dose aspirin helps to prevent thrombosis. Acetylsalicylic acid is colorless or white in crystalline, powder, or granular form. The chemical is odorless and is soluble in water. Salicylate is available for ingestion as tablets, capsules (...) . Repackaging has decreased children's accessibility to lethal amounts, and salicylate's association with Reye syndrome has significantly decreased its use. Still, more than 10,000 tons of aspirin are consumed in the United States each year. Aspirin or aspirin-equivalent preparations (in milligrams) include children's aspirin (80-mg tablets with 36 tablets per bottle), adult aspirin (325-mg tablets), methyl salicylate (eg, oil of wintergreen; 98% salicylate), and Pepto-Bismol (236 mg of non-aspirin

2014 eMedicine.com

30. Toxicity, Salicylate (Overview)

to moderate pain. Aspirin is used as an antipyretic and as an anti-inflammatory agent for the treatment of soft tissue and joint inflammation and vasculitides such as acute rheumatic fever and Kawasaki disease. Aspirin is also used to treat acute coronary syndrome. Low-dose aspirin helps to prevent thrombosis. Acetylsalicylic acid is colorless or white in crystalline, powder, or granular form. The chemical is odorless and is soluble in water. Salicylate is available for ingestion as tablets, capsules (...) . Repackaging has decreased children's accessibility to lethal amounts, and salicylate's association with Reye syndrome has significantly decreased its use. Still, more than 10,000 tons of aspirin are consumed in the United States each year. Aspirin or aspirin-equivalent preparations (in milligrams) include children's aspirin (80-mg tablets with 36 tablets per bottle), adult aspirin (325-mg tablets), methyl salicylate (eg, oil of wintergreen; 98% salicylate), and Pepto-Bismol (236 mg of non-aspirin

2014 eMedicine Emergency Medicine

31. Toxicity, Salicylate (Overview)

to moderate pain. Aspirin is used as an antipyretic and as an anti-inflammatory agent for the treatment of soft tissue and joint inflammation and vasculitides such as acute rheumatic fever and Kawasaki disease. Aspirin is also used to treat acute coronary syndrome. Low-dose aspirin helps to prevent thrombosis. Acetylsalicylic acid is colorless or white in crystalline, powder, or granular form. The chemical is odorless and is soluble in water. Salicylate is available for ingestion as tablets, capsules (...) . Repackaging has decreased children's accessibility to lethal amounts, and salicylate's association with Reye syndrome has significantly decreased its use. Still, more than 10,000 tons of aspirin are consumed in the United States each year. Aspirin or aspirin-equivalent preparations (in milligrams) include children's aspirin (80-mg tablets with 36 tablets per bottle), adult aspirin (325-mg tablets), methyl salicylate (eg, oil of wintergreen; 98% salicylate), and Pepto-Bismol (236 mg of non-aspirin

2014 eMedicine Pediatrics

32. Toxicity, Salicylate (Diagnosis)

to moderate pain. Aspirin is used as an antipyretic and as an anti-inflammatory agent for the treatment of soft tissue and joint inflammation and vasculitides such as acute rheumatic fever and Kawasaki disease. Aspirin is also used to treat acute coronary syndrome. Low-dose aspirin helps to prevent thrombosis. Acetylsalicylic acid is colorless or white in crystalline, powder, or granular form. The chemical is odorless and is soluble in water. Salicylate is available for ingestion as tablets, capsules (...) . Repackaging has decreased children's accessibility to lethal amounts, and salicylate's association with Reye syndrome has significantly decreased its use. Still, more than 10,000 tons of aspirin are consumed in the United States each year. Aspirin or aspirin-equivalent preparations (in milligrams) include children's aspirin (80-mg tablets with 36 tablets per bottle), adult aspirin (325-mg tablets), methyl salicylate (eg, oil of wintergreen; 98% salicylate), and Pepto-Bismol (236 mg of non-aspirin

2014 eMedicine Pediatrics

33. Toxicity, Salicylate (Diagnosis)

to moderate pain. Aspirin is used as an antipyretic and as an anti-inflammatory agent for the treatment of soft tissue and joint inflammation and vasculitides such as acute rheumatic fever and Kawasaki disease. Aspirin is also used to treat acute coronary syndrome. Low-dose aspirin helps to prevent thrombosis. Acetylsalicylic acid is colorless or white in crystalline, powder, or granular form. The chemical is odorless and is soluble in water. Salicylate is available for ingestion as tablets, capsules (...) . Repackaging has decreased children's accessibility to lethal amounts, and salicylate's association with Reye syndrome has significantly decreased its use. Still, more than 10,000 tons of aspirin are consumed in the United States each year. Aspirin or aspirin-equivalent preparations (in milligrams) include children's aspirin (80-mg tablets with 36 tablets per bottle), adult aspirin (325-mg tablets), methyl salicylate (eg, oil of wintergreen; 98% salicylate), and Pepto-Bismol (236 mg of non-aspirin

2014 eMedicine Emergency Medicine

34. Aspirin in Kawasaki disease

and is given for only a short period. Only low dose in the range of three to five milligrams per kilogram body weight is needed for antiplatelet effect and is given for a longer period. Aspirin – ibuprofen interaction Ibuprofen can interfere with the antiplatelet effect of low dose aspirin and should be avoided in children needing low dose aspirin for its antiplatelet effect as with coronary aneurysms in Kawasaki disease. Reye syndrome with aspirin Reye syndrome is a potentially fatal situation (...) with involvement of brain and liver which can occur in children on aspirin when they develop influenza or varicella. It has been reported in children taking high dose aspirin for a prolonged period in Kawasaki disease. But it is not clear whether low dose aspirin given for antiplatelet effect in case of coronary aneurysms also predisposes to Reye syndrome. Similar concerns over Varicella vaccination has also been raised as manufacturers recommend avoiding aspirin for 6 weeks after vaccination. Substitution

2015 Cardiophile MD blog

35. Reye Syndrome

infections, particularly when salicylates are used. Diagnosis is clinical. Treatment is supportive. The cause of Reye syndrome is unknown, but many cases seem to follow infection with influenza A or B or varicella. Using salicylates (generally aspirin ) during such illness increases the risk by as much as 35-fold. This finding has led to a marked decrease in salicylate use in the US since the mid-1980s (except when specifically indicated, such as in and ) and a corresponding decrease in the incidence (...) of Reye syndrome from several hundred annual cases to about 2. The syndrome occurs almost exclusively in children < 18 yr. In the US, most cases occur in late fall and winter. Overview of Reye Syndrome VIDEO The disease affects mitochondrial function, causing disturbance in fatty acid and carnitine metabolism. Pathophysiology and clinical manifestations are similar to a number of inherited metabolic disorders of fatty acid transport and mitochondrial oxidation (see ). Symptoms and Signs The disease

2013 Merck Manual (19th Edition)

36. Aspirin-Induced Acute Liver Injury Full Text available with Trip Pro

Aspirin-Induced Acute Liver Injury Aspirin is thought to be a relatively safe drug in adults. The association of aspirin and Reye syndrome in children is well documented. We report a 41-year-old female with pericarditis who was treated with high-dose aspirin and developed subsequent acute liver injury. After discontinuation of aspirin, liver enzyme elevation and right upper quadrant pain both resolved. We conclude that high-dose aspirin should be considered as a potentially hepatotoxic agent.

2014 ACG case reports journal

37. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

of prior myocardial infarction, history of heart failure, and prior aspirin use. yFor comparative-effectiveness recommendations(Class I and IIa; Level of Evidence A and B only), studies that support the use of comparatorverbs should involve direct comparisons of the treatments or strategies being evaluated. Nishimura et al. JACC Vol. 63, No. 22, 2014 2014 AHA/ACC Valvular Heart Disease Guideline: Executive Summary June 10, 2014:-–- 4 PGL 5.2.0 DTD JAC19929_proof 22 April 2014 10:01 pm IIa and IIb (...) 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary PRACTICE GUIDELINE 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society for Cardiovascular Angiography

2014 Society for Cardiovascular Angiography and Interventions

38. Valvular Heart Disease: Guidelines For the Management of Patients With

clinicians in clinical decision making by describing a range of generally acceptable approaches to the diag- nosis, management, and prevention of speci?c diseases or conditions. The guidelines attempt to de?ne practices that meet the needs of most patients in most circum- stances. The ultimate judgment about care of a particular patient must be made by the clinician and patient in light of all the circumstances presented by that patient. As a result, situations may arise in which deviations from (...) Valvular Heart Disease: Guidelines For the Management of Patients With PRACTICE GUIDELINE 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists

2014 American College of Cardiology

39. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

to the ACC/AHA target population to determine whether the ?ndings should inform a speci?c recommendation. The ACC/AHA practice guidelines are intended to assist clinicians in clinical decision making by describing a range of generally acceptable approaches to the diag- nosis, management, and prevention of speci?c diseases or conditions. The guidelines attempt to de?ne practices that meet the needs of most patients in most circum- stances. The ultimate judgment about care of a particular patient must (...) 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease PRACTICE GUIDELINE 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular

2014 Society for Cardiovascular Angiography and Interventions

40. Kawasaki disease. The importance of prompt recognition and early referral

, there is a small risk that salicylates are associated with an increased risk of Reye syndrome in the setting of active viral infection, although only two cases of Reye syndrome in patients with previous Kawasaki disease have been reported in the literature. Varicella and annual influenza immunisation should be considered in children on long term aspirin therapy; expert advice should be sought. In addition, anti-viral IgG in IVIG may interfere with the efficacy of live vaccines (measles, mumps, rubella [MMR (...) T, Kotzin Bl. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis j 1996;15:1136–8. 17. eladawy M, Dominguez SR, Anderson MS, Glode MP . Abnormal liver panel in acute Kawasaki disease. Pediatr Infect Dis j 2011;30:141–4. 18. Burns jc. Kawasaki disease. Adv Pediatr 2001;48:157–77. 19. Baumer jh, love Sj, Gupta A, haines lc, Maconochie I, Dua jS. Salicylate for the treatment of Kawasaki disease in children. cochrane Database Syst Rev

2014 Clinical Practice Guidelines Portal

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>